Jul 26, 2022 / 08:30PM GMT
John G. McHutchison - Assembly Biosciences, Inc. - CEO, President & Director
Welcome, everyone, and good day. I'm John McHutchison, CEO and President of Assembly Bio, and I'd like to welcome you all to our event today. I'm excited about these research webcast we've been hosting for 2 important reasons. First, I'm thrilled that we are showcasing the outstanding work that Bill Delaney and his talented team of sciences have been doing to capitalize novel programs to combat chronic hepatitis B infection and other viral diseases. And secondly, it's allowed us to invite scientific advisers and clinical experts and collaborators like Professor Ed Gane, who joins us today from New Zealand, to give his expert opinion and view on the tremendous unmet need in diseases like hepatitis B and delta infection and the opportunities for new approaches to make a marked difference for our patients.
Before we turn to the content of today's event, I'd like to quickly touch on a few housekeeping items. I'd like to remind you that we'll be making forward-looking statements. So as always, please refer to our SEC
Assembly Biosciences Inc IFNAR (Interferon-a Receptor Agonist) Research - Corporate Call Transcript
Jul 27, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers